Sometimes even the
experts need experts.
experts need experts.
We match oncologists like you with peer experts so you can get answers to your questions based on practical clinical experience.
.png)
Would you administer CAR-T in a DLBCL patient with central nervous system involvement of their malignancy?
Yes, I have given CAR-T to patients like that. It might make the benefit to risk ratio a bit less favorable, but it’s still a viable option. Let’s discuss further.
.png)
“The oncology field is changing so fast– new drugs, new therapies– it’s overwhelming. I don’t have enough time to distill it all.”
“I value talking to peers who have made it their life’s work to specialize in a specific area. It’s not always easy to find or access them when I have questions.”
“I strictly follow the NCCN and ASCO guidelines, yet lymphoma and myeloma still require a lot of judgment. There is a wide range for discretion in therapeutic decision-making and drug selection.”
“Every 2-4 weeks, new research comes out that causes me to change something in my treatment plans.”
The more our network grows, the better we can help other oncologists develop well-informed treatment plans.
BECOME AN EXPERT.png)
.png)
Join Primum and connect with a vast network of oncologists, so you can set knowledge free.
JOIN OUR COMMUNITYConnect with national oncology specialists, gain advice, and learn about the latest in oncology all on one easy to use app. Curbside with Primum for free.
